274 related articles for article (PubMed ID: 25387576)
1. Ethical challenges posed by the Ebola virus epidemic in West Africa.
Omonzejele PF
J Bioeth Inq; 2014 Dec; 11(4):417-20. PubMed ID: 25387576
[TBL] [Abstract][Full Text] [Related]
2. Ebola, ethics, and the question of culture.
Komesaroff P; Kerridge I
J Bioeth Inq; 2014 Dec; 11(4):413-4. PubMed ID: 25501565
[No Abstract] [Full Text] [Related]
3. Situating the trovan trial with the use of experimental ebola therapies is like comparing an apple with an orange.
Afolabi MO
J Bioeth Inq; 2015 Mar; 12(1):19-20. PubMed ID: 25652573
[No Abstract] [Full Text] [Related]
4. Ebola virus in West Africa: waiting for the owl of Minerva.
Upshur RE
J Bioeth Inq; 2014 Dec; 11(4):421-3. PubMed ID: 25294651
[TBL] [Abstract][Full Text] [Related]
5. Ethical allocation of drugs and vaccines in the West African ebola epidemic.
Gostin LO
Milbank Q; 2014 Dec; 92(4):662-6. PubMed ID: 25492601
[No Abstract] [Full Text] [Related]
6. Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic.
Shah SK; Wendler D; Danis M
Am J Bioeth; 2015; 15(4):11-6. PubMed ID: 25856592
[TBL] [Abstract][Full Text] [Related]
7. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.
Cavaleri M; Thomson A; Salmonson T; Hemmings RJ
Clin Trials; 2016 Feb; 13(1):101-4. PubMed ID: 26768561
[No Abstract] [Full Text] [Related]
8. A US Food and Drug Administration perspective on evaluating medical products for Ebola.
Russek-Cohen E; Rubin D; Price D; Sun W; Cox E; Borio L
Clin Trials; 2016 Feb; 13(1):105-9. PubMed ID: 26768565
[No Abstract] [Full Text] [Related]
9. Scale up the supply of experimental Ebola drugs.
Brady O
Nature; 2014 Aug; 512(7514):233. PubMed ID: 25143079
[No Abstract] [Full Text] [Related]
10. Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use.
Hantel A; Olopade CO
Ann Intern Med; 2015 Jan; 162(2):141-2. PubMed ID: 25322080
[No Abstract] [Full Text] [Related]
11. Ethical considerations in the conduct of research on therapies for the prevention and treatment of Ebola virus disease in developing countries.
Folayan MO; Haire BG
Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):8. PubMed ID: 26740837
[TBL] [Abstract][Full Text] [Related]
12. Will There Be a Cure for Ebola?
Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
[TBL] [Abstract][Full Text] [Related]
13. Ethics of Conducting Clinical Research in an Outbreak Setting.
Edwards KM; Kochhar S
Annu Rev Virol; 2020 Sep; 7(1):475-494. PubMed ID: 32212920
[TBL] [Abstract][Full Text] [Related]
14. Prioritising Healthcare Workers for Ebola Treatment: Treating Those at Greatest Risk to Confer Greatest Benefit.
Satalkar P; Elger BE; Shaw DM
Dev World Bioeth; 2015 Aug; 15(2):59-67. PubMed ID: 25655050
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders' engagement with Ebola therapy research in resource limited settings.
Folayan MO; Brown B; Haire B; Yakubu A; Peterson K; Tegli J
BMC Infect Dis; 2015 Jun; 15():242. PubMed ID: 26113124
[TBL] [Abstract][Full Text] [Related]
16. Health plan.
Nature; 2015 Jun; 522(7554):5. PubMed ID: 26040857
[No Abstract] [Full Text] [Related]
17. US plans to deploy 3000 army personnel to tackle Ebola in west Africa.
McCarthy M
BMJ; 2014 Sep; 348():g5727. PubMed ID: 25234127
[No Abstract] [Full Text] [Related]
18. Ebola: time to act.
Nature; 2014 Sep; 513(7517):143-4. PubMed ID: 25209760
[No Abstract] [Full Text] [Related]
19. [Ebola vaccine, therapeutics, and diagnostics].
Furuyama W; Takada A
Uirusu; 2016; 66(1):63-72. PubMed ID: 28484180
[TBL] [Abstract][Full Text] [Related]
20. Reconsidering the ethical permissibility of the use of unregistered interventions against Ebola virus disease.
Landry JT; Foreman T; Kekewich M
Camb Q Healthc Ethics; 2015 Jul; 24(3):366-9. PubMed ID: 26059962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
